Serotonin toxicity caused by an interaction between fentanyl and paroxetine

Canadian Journal of Anesthesia

Volumn 55, Issue 8, 2008, Pages 521-525

  Rang, Simon T ^a   Field, Jennifer ^a   Irving, Colm ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; PAROXETINE;

ADULT; AGITATION; ANALGESIA; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLONUS; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; DRUG INTERMITTENT THERAPY; DRUG POTENTIATION; FEMALE; FIBROSARCOMA; HUMAN; HYPERTENSION; LABORATORY TEST; MYXOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SEROTONIN SYNDROME; THORAX WALL RECONSTRUCTION; THORAX WALL TUMOR;

EID: 48849086349     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03016672     Document Type: Article

References (18)

1. Stahl S. Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 2nd ed. Cambridge University Press; 2000.
2. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 148: 705-13.
3. Insler SR, Kraenzler EJ, Licina MG, Savage RM, Starr NJ. Cardiac surgery in a patient taking monoamine oxidase inhibitors: an adverse fentanyl reaction. Anesth Analg 1994; 78: 593-7.
4. Ailawadhi S, Sung KW, Carlson LA, Baer MR. Serotonin syndrome caused by interaction between citalopram and fentanyl. J Clin Pharm Ther 2007; 32: 199-202.
5. Noble WH, Baker A. MAO inhibitors and coronary artery surgery: a patient death. Can J Anaesth 1992; 39: 1061-6.
6. Fraser J, South M. Life-threatening fluvoxamine overdose in a 4-year-old child. Intensive Care Med 1999; 25: 548.
7. Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003; 96: 635-42.
8. Codd EE, Shank RP, Schupsky JJ, Raffa RB. Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. J Pharmacol Exp Ther 1995; 274: 1263-70.
9. el-Ganzouri AR, Ivankovich AD, Braverman B, McCarthy R. Monoamine oxidase inhibitors: should they be discontinued preoperatively? Anesth Analg 1985; 64: 592-6.
10. Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth 2005; 95: 434-41.
11. Roy S, Fortier LP. Fentanyl-induced rigidity during emergence from general anesthesia potentiated by venlafexine. Can J Anesth 2003; 50: 32-5.
12. Hegerl U, Bottlender R, Gallinat J, Kuss HJ, Ackenheil M, Moller HJ. The serotonin syndrome scale: first results on validity. Eur Arch Psychiatry Clin Neurosci 1998; 248: 96-103.
13. Bodner RA, Lynch T, Lewis L, Kahn D. Serotonin syndrome. Neurology 1995; 45: 219-23.
14. Lane R, Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol 1997; 17: 208-21.
15. Nisijima K, Shioda K, Yoshino T, Takano K, Kato S. Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome. Neurochem Int 2003; 43: 155-64.
16. Gillman PK. The serotonin syndrome and its treatment. J Psychopharmacol 1999; 13: 100-9.
17. Graudins A, Stearman A, Chan B. Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med 1998; 16: 615-9.
18. Gillman P. PsychoTropical Research [cited 30/3 2008]. Available from URL; http://www.psychotropical.com.